News Sanofi buys Provention and diabetes drug Tzield for $2.9bn T1D prevention drug has been tipped as a blockbuster, boosting Sanofi's diabetes franchise.
News Carl Icahn planning proxy fight at Illumina; report Activist investor claims takeover of liquid biopsy firm Grail points to "reckless" management.
News Forget Merck, now Pfizer is said to be after Seagen Rumour of negotiations comes as Pfizer is facing a steep patent cliff in the next few years.
News Redx joins with Jounce to create cancer, fibrosis biotech Merger is announced after Jounce said it will slash staff and seek partners for its programmes.
News Sun Pharma agrees deal to buy alopecia player Concert India's Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of
News AI specialists Enveda and Basecamp rake in the cash AI-powered drug discovery companies Enveda and Basecamp have completed impressive funding rounds, worth $311m and $140m, respectively.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
